V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010392 | 280005882 | 1.7 | 91 | Palliative (P) | 2018-06-11 | 2018-06-19 | Carboplatin + Etoposide IV 3 day | 02 | N | 280028363 | CARBOPLATIN + ETOPOSIDE |
| 280010393 | 280005885 | 1.69 | 72.4 | Palliative (P) | 2017-12-28 | 2017-12-29 | CAV | N | N | 280028372 | CAV |
| 280010394 | 280011738 | 1.66 | 82.4 | Palliative (P) | 2014-12-15 | 2014-12-15 | CAV | 2 | N | 280028408 | CAV |
| 280010395 | 280005892 | 1.88 | 73 | null | 2017-12-25 | 2018-01-09 | CARBOPLATIN + ETOPOSIDE | 2 | N | 280028410 | CARBOPLATIN + ETOPOSIDE |
| 280010396 | 280009089 | null | 99.6 | Palliative (P) | 2017-05-02 | 2017-05-03 | Carboplatin + Paclitaxel (weekly) | N | N | 280028413 | CARBOPLATIN + PACLITAXEL |
| 280010397 | 280009090 | 1.65 | 40.7 | Palliative (P) | 2015-06-02 | 2015-06-02 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028420 | GEMCITABINE |
| 280010398 | 280005897 | 1.74 | null | Adjuvant (A) | 2013-07-03 | 2013-07-15 | Doxorubicin + Olaratumab | 02 | N | 280028423 | DOXORUBICIN + OLARATUMAB |
| 280010399 | 280005900 | 1.65 | 80.4 | Palliative (P) | 2015-07-21 | 2015-07-21 | Etoposide + Ifosfamide (5 days) | N | N | 280028425 | ETOPOSIDE + IFOSFAMIDE |
| 280010400 | 280005901 | 1.67 | 72 | Palliative (P) | 2016-03-02 | 2016-03-31 | Doxorubicin + Ifosfamide | N | N | 280028429 | DOXORUBICIN + IFOSFAMIDE |
| 280010401 | 280005904 | 1.7 | 78.2 | Adjuvant (A) | 2018-01-02 | 2018-05-29 | VAI (Ifos 3g/m2) | N | N | 280028433 | IRINOTECAN + MDG |
| 280010402 | 280005909 | 1.73 | 77.4 | Not known (9) | 2013-07-17 | 2013-08-10 | Cisplatin +Fluorouracil (3 wk) | null | null | 280028440 | CISPLATIN + FLUOROURACIL |
| 280010403 | 280005910 | 1.68 | 62 | Palliative (P) | 2015-07-17 | 2015-07-24 | Oxaliplatin + Modified de Gramont | 02 | N | 280028441 | OXALIPLATIN + MDG |
| 280010404 | 280005911 | 1.8 | 65.2 | Neo-adjuvant (N) | null | 2014-06-06 | CISPLATIN + GEMCITABINE | N | N | 280028450 | CISPLATIN + GEMCITABINE |
| 280010405 | 280005913 | 1.62 | 43 | Not known (9) | 2017-04-27 | 2017-05-25 | Doxorubicin + Olaratumab | 2 | N | 280028451 | DOXORUBICIN + OLARATUMAB |
| 280010406 | 280005915 | 1.84 | 96 | Neo-adjuvant (N) | 2018-03-23 | 2018-03-23 | VAC | 02 | N | 280028455 | CAV |
| 280010407 | 280005919 | 1.76 | 0 | Adjuvant (A) | 2017-06-06 | 2017-06-27 | Doxorubicin + Olaratumab | N | N | 280028466 | DOXORUBICIN + OLARATUMAB |
| 280010408 | 280005920 | 1.61 | 43.7 | Curative (C) | 2016-02-21 | 2016-02-29 | CISPLATIN + GEMCITABINE | N | N | 280028468 | CISPLATIN + GEMCITABINE |
| 280010409 | 280011925 | 1.61 | null | Adjuvant (A) | 2015-10-16 | 2015-11-10 | Oxaliplatin + Modified de Gramont | Y | null | 280028473 | OXALIPLATIN + MDG |
| 280010410 | 280005923 | 1.75 | 85.2 | Disease modification (D) | 2016-01-07 | 2016-01-17 | EURO-EWING | 2 | N | 280028493 | EURO-EWING |
| 280010411 | 280005924 | 1.6 | 51.5 | Adjuvant (A) | 2016-12-31 | 2017-01-26 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280028496 | CISPLATIN + FLUOROURACIL |
| 280010412 | 280011373 | 1.73 | 0 | Curative (C) | 2015-07-19 | 2015-08-01 | EW EuroEwing 99 : VActC | 02 | null | 280028501 | EURO-EWING |
| 280010413 | 280011373 | null | 46.6 | Palliative (P) | 2018-08-30 | 2018-10-04 | Cisplatin +Fluorouracil (3 wk) | N | N | 280028501 | CISPLATIN + FLUOROURACIL |
| 280010415 | 280011374 | null | null | null | null | 2015-10-06 | Cisplatin +Fluorouracil (3 wk) | N | null | 280028506 | CISPLATIN + FLUOROURACIL |
| 280010416 | 280005930 | 1.68 | 61.1 | Curative (C) | 2018-11-24 | 2018-12-25 | Oxaliplatin + Modified de Gramont | null | null | 280028514 | OXALIPLATIN + MDG |
| 280010417 | 280005931 | null | 79 | Curative (C) | 2015-04-01 | 2015-04-07 | Etoposide + Ifosfamide (3 days) | N | null | 280028519 | ETOPOSIDE + IFOSFAMIDE |
| 280010418 | 280005932 | 1.72 | 49 | Curative (C) | 2016-08-06 | 2016-09-02 | VAI (Ifos 3g/m2) | 02 | N | 280028522 | IRINOTECAN + TEMOZOLOMIDE |
| 280010419 | 280005933 | 1.71 | 74.1 | Palliative (P) | 2016-02-08 | 2016-02-08 | Etoposide + Ifosfamide (5 days) | N | N | 280028533 | ETOPOSIDE + IFOSFAMIDE |
| 280010420 | 280005934 | 1.62 | null | Adjuvant (A) | 2016-01-19 | 2017-07-22 | Doxorubicin + Ifosfamide | 02 | N | 280028533 | DOXORUBICIN + IFOSFAMIDE |
| 280010421 | 280005936 | 1.86 | 24.45 | null | 2018-06-20 | 2018-06-23 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028550 | CETUXIMAB + CISPLATIN + FU |
| 280010422 | 280005938 | 1.64 | 78 | Adjuvant (A) | 2017-01-07 | 2017-01-22 | VAI (Ifos 3g/m2) | 2 | N | 280028558 | VAI |
| 280010423 | 280005938 | 1 | 64.8 | Curative (C) | 2016-04-18 | 2016-04-18 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280028558 | GEMCITABINE |
| 280010424 | 280009110 | 1.73 | 91.55 | Palliative (P) | 2019-08-24 | 2019-09-14 | VAI (Ifos 3g/m2) | Y | N | 280028563 | IRINOTECAN + TEMOZOLOMIDE |
| 280010425 | 280010635 | 1.68 | 67.8 | Palliative (P) | 2016-12-11 | 2016-12-30 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028572 | GEMCITABINE |
| 280010426 | 280009112 | 1.67 | 65.9 | Disease modification (D) | null | 2013-11-26 | VAI (Ifos 3g/m2) | 02 | N | 280028575 | VAI |
| 280010427 | 280009112 | 1.65 | 64 | Palliative (P) | 2015-04-08 | 2015-07-28 | Doxorubicin + Olaratumab | N | null | 280028575 | DOXORUBICIN + OLARATUMAB |
| 280010428 | 280009114 | 1.82 | null | Neo-adjuvant (N) | 2013-02-06 | 2013-02-13 | CISPLATIN + FLUOROURACIL | N | N | 280028579 | CISPLATIN + FLUOROURACIL |
| 280010429 | 280005947 | 1.72 | 61.1 | Palliative (P) | 2016-06-26 | 2016-07-13 | Oxaliplatin + Modified de Gramont | 2 | N | 280028590 | OXALIPLATIN + MDG |
| 280010430 | 280005948 | 1.68 | 64.8 | Neo-adjuvant (N) | 2017-06-07 | 2017-06-22 | DE-ESCALATE TRIAL | null | null | 280028592 | DE-ESCALATE TRIAL |
| 280010431 | 280005950 | 1.88 | null | Palliative (P) | 2014-01-18 | 2014-01-18 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028593 | GEMCITABINE |
| 280010432 | 280005954 | 1.72 | 64.8 | Palliative (P) | 2015-11-26 | 2016-05-04 | DE-ESCALATE TRIAL | N | N | 280028597 | DE-ESCALATE TRIAL |
| 280010433 | 280005958 | 1.8 | 59.7 | Palliative (P) | 2017-09-17 | 2017-10-08 | Oxaliplatin + Modified de Gramont | N | N | 280028610 | OXALIPLATIN + MDG |
| 280010434 | 280005960 | 1.79 | 68 | Neo-adjuvant (N) | 2018-03-11 | 2018-06-08 | GEMCITABINE | null | null | 280028629 | GEMCITABINE |
| 280010435 | 280005962 | 1.77 | 92.8 | Palliative (P) | 2015-09-03 | 2015-09-12 | DE-ESCALATE TRIAL | N | N | 280028640 | DE-ESCALATE TRIAL |
| 280010436 | 280005962 | null | 36.3 | Curative (C) | 2015-01-15 | 2015-03-26 | DE-ESCALATE TRIAL | N | N | 280028640 | DE-ESCALATE TRIAL |
| 280010437 | 280009123 | 1.73 | 71 | Palliative (P) | 2017-11-27 | 2017-12-16 | Etoposide + Ifosfamide (5 days) | 02 | N | 280028652 | ETOPOSIDE + IFOSFAMIDE |
| 280010438 | 280005967 | 1.77 | 116.5 | Palliative (P) | 2018-06-16 | 2018-06-20 | Doxorubicin + Ifosfamide | N | N | 280028662 | DOXORUBICIN + IFOSFAMIDE |
| 280010439 | 280005970 | 1.7 | 68.4 | Disease modification (D) | 2018-11-02 | 2018-11-05 | Doxorubicin + Ifosfamide | 02 | N | 280028664 | DOXORUBICIN + IFOSFAMIDE |
| 280010440 | 280005973 | 1.7 | 70 | Curative (C) | 2015-07-16 | 2015-07-16 | FLUOROURACIL + IRINOTECAN | 02 | N | 280028669 | VAI |
| 280010441 | 280011382 | 1.57 | 58.6 | Curative (C) | 2017-06-09 | 2017-07-05 | Irinotecan + Modified De Gramont | null | null | 280028670 | IRINOTECAN + MDG |
| 280010442 | 280011930 | 1.75 | 12.4 | Curative (C) | 2015-12-20 | 2016-02-12 | CISPLATIN + FLUOROURACIL | null | null | 280028677 | CISPLATIN + FLUOROURACIL |